CIK: 0001773195 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 13, 2023
Total Value ($000): $254,990 (96.0% shares, 4.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | CHINOOK THERAPEUTICS INC | 818,035 | $21,433 | 8.4% | $16.39 | — | COM | 16961L106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 70,000 | $20,318 | 8.0% | $80.21 | +21.9% | COM | 558868105 |
| BMY | BRISTOL MYERS SQUIBB CO | 175,000 | $12,591 | 4.9% | — | — | Put | 110122108 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 190,767 | $12,524 | 4.9% | $63.72 | -5.2% | COM | G31249108 |
| ASND | ASCENDIS PHARMA A S | 70,997 | $8,671 | 3.4% | $116.37 | — | SPONSORED ADR | 04351P101 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 80,000 | $8,279 | 3.2% | $93.88 | 0.0% | COM | 09061G101 |
| — | PROMETHEUS BIOSCIENCES INC | 75,000 | $8,250 | 3.2% | $93.00 | — | COM | 74349U108 |
| — | VERONA PHARMA PLC | 312,498 | $8,166 | 3.2% | $10.22 | — | SPONSORED ADR | 925050106 |
| VTYX | VENTYX BIOSCIENCES INC | 240,623 | $7,890 | 3.1% | $24.34 | +21.7% | COM | 92332V107 |
| — | MORPHIC HLDG INC | 280,921 | $7,515 | 2.9% | $39.02 | — | COM | 61775R105 |
| ACLX | ARCELLX INC | 240,143 | $7,440 | 2.9% | $17.66 | +29.9% | COMMON STOCK | 03940C100 |
| — | CYMABAY THERAPEUTICS INC | 1,143,531 | $7,170 | 2.8% | $3.32 | — | COM | 23257D103 |
| — | ASTRIA THERAPEUTICS INC | 472,482 | $7,035 | 2.8% | $9.94 | — | COM | 04635X102 |
| — | CEREVEL THERAPEUTICS HLDNG I | 215,000 | $6,781 | 2.7% | $31.54 | — | COM | 15678U128 |
| — | INARI MED INC | 90,000 | $5,720 | 2.2% | $91.64 | — | COM | 45332Y109 |
| MRNA | MODERNA INC | 30,000 | $5,389 | 2.1% | — | — | Put | 60770K107 |
| AMGN | AMGEN INC | 20,000 | $5,253 | 2.1% | — | — | Put | 031162100 |
| — | HORIZON THERAPEUTICS PUB L | 45,000 | $5,121 | 2.0% | $113.80 | — | SHS | G46188101 |
| RCKT | ROCKET PHARMACEUTICALS INC | 258,115 | $5,051 | 2.0% | $25.12 | -26.7% | COM | 77313F106 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 110,000 | $4,903 | 1.9% | $33.14 | +7.7% | COM NEW | 15117B202 |
| — | BELLUS HEALTH INC NEW | 573,678 | $4,716 | 1.8% | $5.71 | — | COM NEW | 07987C204 |
| AZN | ASTRAZENECA PLC | 60,000 | $4,068 | 1.6% | $61.36 | — | SPONSORED ADR | 046353108 |
| CYTK | CYTOKINETICS INC | 87,601 | $4,014 | 1.6% | $45.45 | -5.5% | COM NEW | 23282W605 |
| — | BRIDGEBIO PHARMA INC | 10,000,000 | $3,895 | 1.5% | $0.47 | — | NOTE 2.250% 2/0 | 10806XAD4 |
| — | BRIDGEBIO PHARMA INC | 7,500,000 | $3,410 | 1.3% | $0.74 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| KURA | KURA ONCOLOGY INC | 268,747 | $3,335 | 1.3% | $23.45 | -38.0% | COM | 50127T109 |
| VKTX | VIKING THERAPEUTICS INC | 350,000 | $3,290 | 1.3% | $3.61 | +23.5% | COM | 92686J106 |
| LNTH | LANTHEUS HLDGS INC | 60,630 | $3,090 | 1.2% | $42.08 | +46.6% | COM | 516544103 |
| PCVX | VAXCYTE INC | 60,000 | $2,877 | 1.1% | $39.24 | 0.0% | COM | 92243G108 |
| — | VERONA PHARMA PLC | 105,000 | $2,744 | 1.1% | $10.22 | — | Call | 925050106 |
| GERN | GERON CORP | 1,056,500 | $2,557 | 1.0% | — | — | Put | 374163103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 100,000 | $2,545 | 1.0% | $23.32 | 0.0% | COM | 87164F105 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 375,000 | $2,396 | 0.9% | $7.81 | 0.0% | COM | 462260100 |
| VKTX | VIKING THERAPEUTICS INC | 250,000 | $2,350 | 0.9% | $3.61 | +23.5% | Call | 92686J106 |
| — | KARYOPHARM THERAPEUTICS INC | 661,264 | $2,248 | 0.9% | $3.40 | — | COM | 48576U106 |
| COGT | COGENT BIOSCIENCES INC | 193,064 | $2,232 | 0.9% | $8.99 | +37.9% | COM | 19240Q201 |
| — | POINT BIOPHARMA GLOBAL INC | 303,218 | $2,210 | 0.9% | $7.70 | — | COM | 730541109 |
| NVAX | NOVAVAX INC | 200,000 | $2,056 | 0.8% | — | — | Put | 670002401 |
| GERN | GERON CORP | 837,000 | $2,026 | 0.8% | — | — | Call | 374163103 |
| XENE | XENON PHARMACEUTICALS INC | 50,000 | $1,972 | 0.8% | $36.42 | 0.0% | COM | 98420N105 |
| ARGX | ARGENX SE | 5,000 | $1,894 | 0.7% | $378.83 | — | SPONSORED ADR | 04016X101 |
| NVCR | NOVOCURE LTD | 25,000 | $1,834 | 0.7% | — | — | Call | G6674U108 |
| — | ALPINE IMMUNE SCIENCES INC | 247,891 | $1,822 | 0.7% | $7.28 | — | COM | 02083G100 |
| — | VINCERX PHARMA INC | 1,492,771 | $1,523 | 0.6% | $13.47 | — | COM NEW | 92731L106 |
| — | PRECIGEN INC | 1,500,000 | $1,488 | 0.6% | $0.97 | — | NOTE 3.500% 7/0 | 46122TAA0 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 460,328 | $1,427 | 0.6% | $3.58 | — | SPONSORED ADS | 152309100 |
| — | ESPERION THERAPEUTICS INC NE | 2,500,000 | $1,364 | 0.5% | $0.55 | — | NOTE 4.000%11/1 | 29664WAB1 |
| KALV | KALVISTA PHARMACEUTICALS INC | 188,292 | $1,273 | 0.5% | $9.77 | -45.2% | COM | 483497103 |
| BCAB | BIOATLA INC | 150,000 | $1,238 | 0.5% | $8.30 | 0.0% | COM | 09077B104 |
| DYN | DYNE THERAPEUTICS INC | 92,170 | $1,068 | 0.4% | $11.57 | 0.0% | COM | 26818M108 |
| LIANY | LIANBIO | 650,000 | $1,066 | 0.4% | $3.10 | — | SPONSORED ADS | 53000N108 |
| NRIX | NURIX THERAPEUTICS INC | 80,000 | $878 | 0.3% | $12.06 | 0.0% | COM | 67080M103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 40,000 | $780 | 0.3% | $19.77 | 0.0% | COM | 604749101 |
| FHTX | FOGHORN THERAPEUTICS INC | 109,991 | $702 | 0.3% | $7.54 | 0.0% | COM | 344174107 |
| — | SEAGEN INC | 5,000 | $643 | 0.3% | $128.51 | — | COM | 81181C104 |
| CNTX | CONTEXT THERAPEUTICS INC | 883,654 | $584 | 0.2% | $2.08 | -48.1% | COM | 21077P108 |
| — | INOZYME PHARMA INC | 500,000 | $525 | 0.2% | $1.05 | — | COM | 45790W108 |
| NUVB | NUVATION BIO INC | 250,000 | $480 | 0.2% | $2.02 | 0.0% | COM CL A | 67080N101 |
| — | IMMATICS N.V | 187,204 | $470 | 0.2% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| MIST | MILESTONE PHARMACEUTICALS IN | 100,000 | $396 | 0.2% | $5.26 | 0.0% | COM | 59935V107 |
| SCLXW | SCILEX HOLDING CO | 18,099 | $3 | 0.0% | $0.19 | — | *W EXP 11/10/202 | 80880W114 |
| — | MEDICUS SCIENCES ACQUISITION | 33,333 | $3 | 0.0% | $1.02 | — | *W EXP 02/12/202 | G5960S124 |
| — | SCILEX HOLDING CO | 463 | $2 | 0.0% | $3.99 | — | COM | 80880W106 |